✦ LIBER ✦

Hematopoietic progenitor cell collection in patients with chronic myelogenous leukemia in complete cytogenetic remission after imatinib mesylate therapy

✍ Scribed by Bashir, Qaiser; De Lima, Marcos J.; Mcmannis, John D.; Garcia-Manero, Guillermo; Shpall, Elizabeth; Kantarjian, Hagop; Cortes, Jorge E.; O'Brien, Susan M.; Jones, Dan; Qazilbash, Muzaffar; Wei, Wei; Giralt, Sergio A.; Champlin, Richard E.; Hosing, Chitra

Book ID: 120990983
Publisher: Informa plc
Year: 2010
Tongue: English
Weight: 196 KB
Volume: 51
Category: Article
ISSN: 1042-8194
DOI: 10.3109/10428194.2010.501534

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Persistence of malignant hematopoietic p

Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment

✍ Bhatia, R. 📂 Article 📅 2003 🏛 American Society of Hematology 🌐 English ⚖ 80 KB

Sequential transient novel chromosomal t

Sequential transient novel chromosomal translocations in a patient with chronic myelogenous leukemia in complete cytogenetic remission after therapy with imatinib mesylate

✍ George Papaioannou; Anastasia Athanasiadou; Georgia Voutiadou; Maria Gaitatzi; I 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 76 KB

Peripheral blood progenitor cell collect

Peripheral blood progenitor cell collection in chronic myeloid leukemia patients with complete cytogenetic response after treatment with imatinib mesylate

✍ Paolo Perseghin; Carlo Gambacorti-Passerini; Lucia Tornaghi; Maria Dassi; Pietro 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 89 KB

Sustained complete cytogenetic remission

Sustained complete cytogenetic remission in a patient with chronic myeloid leukemia after discontinuation of imatinib mesylate therapy

✍ Seiichi Okabe; Tetsuzo Tauchi; Yuko Ishii; Daigo Akahane; Kousuke Nunoda; Seiko 📂 Article 📅 2007 🏛 Carden Jennings Publishing 🌐 English ⚖ 45 KB

Emergence of Ph negative clones in chron

Emergence of Ph negative clones in chronic myeloid leukemia (CML) patients in complete cytogenetic remission after therapy with imatinib mesylate (STI)

✍ Alessandro Gozzetti; Daniela Tozzuoli; Rosaria Crupi; Sara Gentili; Monica Bocch 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

Chronic myelogenous leukemia in T cell l

Chronic myelogenous leukemia in T cell lymphoid blastic phase achieving durable complete cytogenetic and molecular remission with imatinib mesylate (STI571; Gleevec) therapy

✍ Ehab Atallah; Moshe Talpaz; Susan O'brien; Mary Beth Rios; Jie Qiang Guo; Ralph 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

## Abstract ## BACKGROUND A T cell lymphoid blastic phase of chronic myelogenous leukemia (CML) is a rare occurrence, with only a few reported cases worldwide. Standard therapy for such patients is undetermined. Imatinib mesylate, a Bcr‐Abl tyrosine kinase inhibitor, has shown activity in CML. ##